BigHat is delighted to welcome Amol Pawar to the BigHat advisory team! Amol is a healthcare finance executive with over 15 years of experience in defining and executing business strategy. Currently he is the Head of Corporate Development at Zentalis Pharmaceuticals. Prior to Zentalis, Amol was an investment banker at PJT Partners and Deutsche Bank with additional time in equity research covering SMID-cap biotech companies at Stifel. He has also spent time at healthcare startup companies in the fields of neurology and high throughput histopathology. Amol holds a PhD in Chemistry from the University of Cambridge as a Gates Scholar, an MS (Chemistry) and BA (Biochemistry) from the University of Pennsylvania as a Vagelos Scholar.
Read more at https://www.bighatbio.com/about/
